GSK Hones OTCs As “Sharp End” Of Consumer Products Business
This article was originally published in The Tan Sheet
Executive Summary
Glaxo’s OTC business is “the very best end of consumer goods as opposed to being a poor relation of pharmaceuticals,” says Emma Walmsley, GSK Consumer Healthcare president.